About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Clinical Transplantation
›
top-articles
Clinical Transplantation
1.8
(top 50%)
impact factor
5.3K
(top 5%)
papers
93.7K
(top 5%)
citations
89
(top 5%)
h
-index
1.8
(top 50%)
impact factor
6.2K
all documents
98.4K
doc citations
128
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Low-dose dopamine after kidney transplantation: assessment by Doppler ultrasound
Clinical Transplantation
1999
533
2
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004
Clinical Transplantation
2005
500
3
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation
2019
418
4
Infectious complications after kidney transplantation: current epidemiology and associated risk factors
Clinical Transplantation
2006
341
5
Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice
Clinical Transplantation
2019
307
6
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies*
Clinical Transplantation
2004
293
7
BK
polyomavirus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation
2019
257
8
Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)
Clinical Transplantation
1996
248
9
Cytomegalovirus in transplantation ? challenging the status quo
Clinical Transplantation
2007
245
10
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management
Clinical Transplantation
2003
234
11
Guidelines for the treatment and management of new-onset diabetes after transplantation1.
Clinical Transplantation
2005
228
12
Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers
Clinical Transplantation
2005
218
13
Management of biliary tract complications after orthotopic liver transplantation
Clinical Transplantation
2004
209
14
Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation
2019
206
15
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity
Clinical Transplantation
2000
205
16
Central nervous system complications in liver transplant recipients - incidence, timing, and long-term follow-up
Clinical Transplantation
2000
192
17
The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation
Clinical Transplantation
2003
185
18
Gastroesophageal reflux disease in lung transplant recipients
Clinical Transplantation
2003
183
19
Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation
Clinical Transplantation
1999
182
20
Venous complications after orthotopic liver transplantation
Clinical Transplantation
2000
173
21
Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation
Clinical Transplantation
2001
166
22
Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation
2019
160
23
Pneumocystis jiroveci
in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation
2019
159
24
Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes
Clinical Transplantation
2008
158
25
Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications
Clinical Transplantation
2001
157
26
Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot study
Clinical Transplantation
2008
157
27
Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review
Clinical Transplantation
2003
149
28
Wound complications following kidney and liver transplantation
Clinical Transplantation
2006
149
29
Long-term outcome of liver transplantation for autoimmune hepatitis
Clinical Transplantation
2004
140
30
Risk factors for slow graft function after kidney transplants: a multivariate analysis
Clinical Transplantation
2002
136
31
Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity
Clinical Transplantation
2007
136
32
Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease*
Clinical Transplantation
2004
134
33
RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation
2019
134
34
Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation
2019
131
35
Risk factors for acute renal failure requiring dialysis after liver transplantation
Clinical Transplantation
1998
129
36
Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients
Clinical Transplantation
2000
128
37
Correlates of noncompliance among renal transplant recipients
Clinical Transplantation
1994
126
38
Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation
Clinical Transplantation
1999
125
39
Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it
Clinical Transplantation
2000
125
40
Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation
Clinical Transplantation
2001
124
41
Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool
Clinical Transplantation
2003
124
42
Impact of rituximab therapy for treatment of acute humoral rejection
Clinical Transplantation
2009
124
43
CMV‐hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta‐analysis
Clinical Transplantation
2008
122
44
Significance of the donor age effect on kidney transplants
Clinical Transplantation
1997
122
45
Expanding the donor pool: use of marginal donors for solid organ transplantation
Clinical Transplantation
1996
120
46
Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy
Clinical Transplantation
1998
120
47
Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil
Clinical Transplantation
2005
119
48
Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post‐transplant outcomes
Clinical Transplantation
2011
119
49
Correlates of support for organ donation among three ethnic groups
Clinical Transplantation
1999
118
50
Risk factors for early primary graft dysfunction after lung transplantation: a registry study
Clinical Transplantation
2009
116
site/software ©
exaly
; All materials licenced under
CC by-SA
.